A股異動丨康希諾(688185.SH)大跌超10% 上半年淨虧損擴大46.65%至1.02億元
格隆匯8月24日丨康希諾(688185.SH)大跌超10%,報313.6元,低見303元,較其上市首日最高價477元累跌約36%;康希諾生物(6185.HK)則跌4.32%。康希諾(688185.SH)公佈,2020年半年度,公司營業收入403萬元,同比增長111.43%;歸屬於上市公司股東的淨虧損1.02億元,虧損同比擴大46.65%;每股虧損0.46元。截至報告期末,公司尚無產品上市銷售,公司的疫苗研發項目持續推進中,多個創新疫苗處於臨牀試驗研究階段,研發支出投入持續加大,因此公司2020年上半年度仍未實現盈利。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.